Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?
about
Non-small cell lung cancer: current treatment and future advancesIs surgery still the optimal treatment for stage I non-small cell lung cancer?Radioresistance of Brain TumorsStereotactic body radiotherapy in lung cancer: an updateThe radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancerRadiation dose effect in locally advanced non-small cell lung cancerTreatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?A critical review of recent developments in radiotherapy for non-small cell lung cancerChallenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy?Stereotactic radiotherapy for early lung cancer: Evidence-based approach and future directionsCritical structure sparing in stereotactic ablative radiotherapy for central lung lesions: helical tomotherapy vs. volumetric modulated arc therapyAnalysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapyLobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data.Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy.Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients.Design, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology GroupMultimodal chest surface motion data for respiratory and cardiovascular monitoring applications.Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancerThe impact of cine EPID image acquisition frame rate on markerless soft-tissue tracking.Maximum standardized uptake value on FDG-PET predicts survival in stage I non-small cell lung cancer following carbon ion radiotherapy.Radiofrequency ablation for early-stage nonsmall cell lung cancer.Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancerPercutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer.Carbon ion therapy for early-stage non-small-cell lung cancer.Correlation between tumor size and blood volume in lung tumors: a prospective study on dual-energy gemstone spectral CT imaging.Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors.Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy.Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report.SBRT in operable early stage lung cancer patients.Alternatives to surgery in early stage disease-stereotactic body radiotherapyFeasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments.Radiation oncology and medical physicsRib fracture after stereotactic radiotherapy on follow-up thin-section computed tomography in 177 primary lung cancer patientsStereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.Imaging characteristics of local recurrences after stereotactic body radiation therapy for stage I non-small cell lung cancer: Evaluation of mass-like fibrosis.Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversiesStereotactic ablative radiotherapy (SABR) for lung cancer: What does the future hold?
P2860
Q26740333-ECA015AF-B9EE-45E6-897F-CACAAE78576DQ26749371-CC173B63-6DCA-4965-992E-12DC99851373Q26752579-A716201A-BDAC-4A24-8D0C-0337CA9FE459Q26781806-8DC14F54-66DB-490F-BE07-092A1636EE71Q26799892-39C509C4-E362-4AA1-A873-5886C743D2D1Q26823043-CFAEC9A3-D3BE-470B-8766-F7ED18C7F3B5Q26853124-36A835D5-0BDA-4C20-A94D-C7F5683449B1Q28079625-5264CA9A-404F-4228-ADB0-A5CBCFB0C6DDQ28083924-6EB466CD-FE75-4B8B-A19E-509D4E1F122AQ28085744-57A5AF66-1DB9-4E71-B4A4-B1E736D103EBQ28950857-D864982D-4C28-4E83-8F5F-599942405D62Q30585045-742B7B18-B983-40B2-AA46-1F94EF46C07FQ30640824-1A9026F2-71AF-4CF4-830A-CD417223D350Q30656342-774352E9-0451-406E-AB98-014B5C574067Q30985297-BD3B7BC0-3390-4D27-BE8B-8038C921E13EQ30993385-B2F8A709-AC16-4D72-AD34-8658E4645A40Q31151418-1C9705B2-A1B4-4874-BB23-30EDB7857A1EQ33582628-FAB419D5-C04A-4AAE-8F4E-C436BBC4C4F0Q33601913-DD27DCE3-877C-4630-A2C1-2EADDC1B1DB6Q33645619-D08CC8BB-F69E-4CB5-866A-99866321A1E6Q33645624-15C4444E-9528-45FA-9695-181CC398FACAQ33655601-66C8F2E7-527D-4042-99CE-B41AEDA4667FQ33750851-0B53D79A-B3BC-4DE7-AD95-D96334A75E88Q33787072-E0427BDC-3352-47F6-8675-DDEF13842F38Q33813917-2B281132-733B-481B-8C07-ED0B2CB0DB6DQ34193728-5CCC32C9-DB64-4E4F-91F5-82421175285FQ34253457-8392D308-1F7D-4F71-8ACF-7DFD83B9A6A4Q34366518-19120A41-48F4-49B7-96BD-B8AB463AE00AQ34580469-8484E41C-D818-4DEC-B28C-8415AC0316F7Q35074232-3D53575F-252B-4DF0-A05A-EED5691B1088Q35157799-6C540FAC-324F-47A8-BC18-5D1EDCD536CDQ35200592-578C6029-9755-4108-B6A1-C78CBE64664CQ35200644-A8DAEFD3-50F2-4F6B-B131-0E31F2CDDF9EQ35232033-0B288418-4737-4B6F-AA29-F5338A719966Q35401756-1415DA04-A319-40B0-A491-D4FA134EF97EQ35541222-3883BA92-A706-4834-BA94-9AB801FFB8ADQ35646076-8CC88803-F33D-4779-A0FC-7AD1145968B6Q35663626-2B203879-09BA-4365-9116-DBD485003EA5Q35667829-3AFCFF93-2CDF-4183-B55D-22235320D936Q35667834-737AF1E4-C917-4AA2-85BA-17D021CBD062
P2860
Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stereotactic body radiotherapy ...... SBRT be comparable to surgery?
@en
type
label
Stereotactic body radiotherapy ...... SBRT be comparable to surgery?
@en
prefLabel
Stereotactic body radiotherapy ...... SBRT be comparable to surgery?
@en
P2093
P1476
Stereotactic body radiotherapy ...... SBRT be comparable to surgery?
@en
P2093
Atsushi Ouchi
Atsuya Takeda
Hiroki Shirato
Hiroshi Onishi
Katsuyuki Karasawa
Kazushige Hayakawa
Kotaro Gomi
Masaharu Fujino
Masahiro Hiraoka
P304
P356
10.1016/J.IJROBP.2009.07.1751
P407
P577
2010-07-16T00:00:00Z